Items tagged with Access
Webinar: Ethical considerations on standard of care and post-trial access (post)
Community Partners, a group of community representatives working across the five U.S. National Institutes of Health (NIH) HIV/AIDS clinical trials networks, will host a webinar focused on some of the ethical considerations around standard of care and practical challenges of post-trial access.
Patients of Ukraine celebrate access to tuberculosis medications (post)
After relentless advocacy by patient groups in Ukraine, a partnership between the United Nations Development Program (UNDP) and the Ukraine Ministry of Health has resulted in the successful procurement of first and second-line drugs for tuberculosis (TB). Through their open bidding process, UNDP was able to secure significantly lower prices for 15 of the 18 TB medicines they will purchase on behalf of Ukraine, and save USD 1 million, which could be reinvested to treat an additional 28,000 patients with drug-sensitive TB or 700 patients with drug-resistant TB. Delivery of the first shipment of medicines is expected as early as April.
UN High-Level Panel: Ideas for change to global health and intellectual property system proliferate (post)
Public health advocates, academics, patients, governments and others this week presented further ideas to the United Nations Secretary-General’s High-Level Panel on Access to Medicines on ways to break the longstanding pattern of expensive medical products around the world as a way to pay for research and development.
MSF welcomes Ministry of Commerce clarification on compulsory licensing: warns US pressure on India will continue (post)
New Delhi, 23 March 2016 - The Indian Government recently responded to media reports that they had assured the US India Business Council that they would not grant compulsory licences on medicines - overriding a patent to allow for the production of affordable generic versions of medicines under licence - in the future.
Myanmar: Two new drugs launched ahead of World TB Day (post)
March 23, 2016 - Myanmar will have cause to celebrate World TB Day tomorrow, as health organisations start attacking some of the most difficult-to-cure forms of the disease with two new drugs.
MSF responds to Indian Health Ministry’s notification on ban of 344 fixed dose combinations drugs (post)
“MSF welcomes the Indian Ministry of Health’s 10th March notification [i] on the prohibition of manufacture, sale and distribution of certain fixed dose combination (FDCs) drugs that put public health and lives of people at risk. The list of banned drugs includes several FDCs containing multiple antibiotics that have long been used injudiciously, contributing to the development of resistant strains of infection-causing bacteria.
Private aid agency in South Korea delivers TB medicines to North Korea (post)
SEOUL, March 25 -- A private aid agency in South Korea said Friday that it has delivered medicines to treat tuberculosis to North Korea, the first humanitarian aid to the North after Pyongyang carried out its fourth nuclear test in January.
The Zika loopholes (post)
March 25, 2016 - Last week, the Senate voted to add Zika to the list of neglected diseases for which pharmaceutical companies and other entities doing research and development for neglected diseases can receive a fast-track review for another product from the Food and Drug Administration. At first glance this seems like an apt move—the program was designedto encourage the development of treatments and vaccines for neglected diseases, and Zika is a disease for which there are currently no treatments or vaccines.
Delamanid clinical access programme expected in South Africa (post)
The South African National Department of Health is expected to roll out a clinical access programme to allow drug-resistant tuberculosis (DR-TB) patients access to the new drug delamanid.
India: Drug-resistant TB and a promising drug (post)
World TB Day commemoration events for 2016 have just concluded. The Ministry of Health and Family Welfare announced that bedaquiline, the first new TB drug in over 40 years, will be now available in India. It had been given accelerated approval by the U.S. Food and Drug Administration in December 2012. Announcing its availability, the Ministry indicated it would be available only at six sites; in the first lot, only 600 doses will come.
Page 19 of 83 · Total posts: 0
←First 18 19 20 Last→